Johnson & Johnson (JNJ) announced that the FDA has granted Fast Track designation to its Posdinema, a monoclonal antibody ...

House Speaker Mike Johnson often says he sees himself as the quarterback and President-elect Donald Trump as the coach ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

Fans of the late former President Jimmy Carter weren't happy to see Speaker Mike Johnson (R-LA) and Senate Majority Leader ...

Social media users responded with a stark reminder after House Speaker Mike Johnson (R-La.) on Tuesday positively talked up ...

Brandon Johnson often speaks of his concern for the welfare of Chicago’s children, usually in the context of seeking more taxpayer money for Chicago Public Schools and supporting higher wages and more ...

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) and keeping the price ...

JNJ has an attractive 3.41% dividend yield comparable to the yield on long-term bonds. Given the lack of price movement and ...

Johnson & Johnson (JNJ) closed at $146.18 in the latest trading session, marking a +1.75% move from the prior day. The stock outpaced the S&P 500's daily loss of 1.11%. Elsewhere, the Dow saw a ...

The jury determined that Johnson & Johnson was negligent and that the company intentionally misrepresented the safety of its ...

Johnson & Johnson closed $22.62 below its 52-week high ($168.85), which the company achieved on September 4th.

Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...